Cancer Health Disparities

Here has been substantial progress in cancer treatment, screening, diagnosis, and prevention over the past several decades, addressing cancer health disparities—such as higher cancer death rates, less frequent use of proven screening tests, and higher rates of advanced cancer diagnoses—in certain populations is an area in which progress has not kept pace.
 
These disparities are frequently seen in people from low-socioeconomic groups, certain racial/ethnic populations, and those who live in geographically isolated areas.
 
Documented cancer health disparities include: A higher incidence of a particularly aggressive form of breast cancer (the triple-negative subtype) among African American women than women of other racial/ethnic groups
 
substantially higher rates of prostate cancer incidence and death among African American men than men of other racial/ethnic groups
 
higher rates of kidney cancer among American Indian and Alaska Natives than other racial/ethnic groups. Higher rates of liver cancer among Asian and Pacific Islanders than other racial/ethnic groups
 
higher rates of cervical cancer incidence and death among Hispanic and African American women than women of other racial/ethnic groups. Many of the same population groups that experience cancer health disparities are also significantly underrepresented in cancer clinical trials.
 
There has been some recent evidence of progress against cancer health disparities, including reductions in lung and prostate cancer deaths among African American men over the past decade. But researchers and public health officials agree that progress has come too slowly, and the cost of disparities—in terms of premature deaths, lost productivity, and the impact on communities—remains substantial and must be addressed. Cancer disparities and equity research is needed to understand why some groups of people may be more or less likely to develop cancer, experience cancer-related health problems, or die from cancer than other groups of people.

    Related Conference of Cancer Health Disparities

    March 10-11, 2025

    4th International Conference on Biomarkers and Clinical Research

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    23rd International Conference on Cancer Biology and Cell Science

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    April 07-08, 2025

    15th World Congress on Breast Cancer

    Vancouver, Canada
    April 21-22, 2025

    16th International Conference on Cancer Stem Cell & Oncology Research

    Amsterdam, Netherlands
    April 23-24, 2025

    15th World Congress on Breast Cancer Research & Therapies

    Rome, Italy
    May 05-06, 2025

    38th Conference on Preventive Oncology and Diagnostic Cancer

    Rome, Italy
    June 09-10, 2025

    3rd International Conference on Cancer Biology and Therapeutics

    Rome, Italy
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    June 19-20, 2025

    7th International Conference on Women Oncology

    London, UK
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    October 22-23, 2025

    4th Experts Meeting on Cancer Medicine, Radiology & Treatment

    Paris, France
    November 24-25, 2025

    47th Euro-Global Summit on Cancer Therapy & Radiation Oncology

    Barcelona, Spain

    Cancer Health Disparities Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in